Effect of ACE inhibitors on angiotensin II in rat mesangial cells cultured in high glucose

Biochemical and Biophysical Research Communications

Volumn 357, Issue 4, 2007, Pages 1040-1045

  Singh, Rekha ^a   Leehey, David J ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Angiotensin II; Angiotensin converting enzyme (ACE) inhibitor; Glucose; Mesangial cells

Indexed keywords

ANGIOTENSIN II; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL LYSATE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; GLOMERULUS; MALE; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSE; MALE; MESANGIAL CELLS; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

RATTUS;

EID: 34247847648     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.04.038     Document Type: Article

References (20)

1. Leehey D.J., Singh A.K., and Singh R. Angiotensin II and its receptors in the pathogenesis of diabetic nephropathy. In: Cortes P., and Mogensen C.E. (Eds). The Diabetic Kidney (2006), Humana Press Inc., New Jersey 3-21
2. Kagami S., Border W.A., Miller D.E., and Noble N.A. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells. J. Clin. Invest. 93 (1994) 2431-2437
3. Singh R., Alavi N., Singh A.K., and Leehey D.J. Role of angiotensin II in glucose-induced inhibition of mesangial matrix degradation. Diabetes 48 (1999) 2066-2073
4. Lewis E.J., Hunsicker L.G., Bain R.P., and Rohde R.D. Collaborative Study Group: the effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N. Engl. J. Med. 329 (1993) 1456-1462
5. Lewis E.J., Hunsicker L.G., Clarke W.R., Berl T., Pohl M.A., Lewis J.B., Ritz E., Atkins R.C., Rohde R.D., and Raz I. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N. Engl. J. Med. 345 (2001) 851-860
6. Perico N., Amuchastegui C.S., Malanchini B., Bertani T., and Remuzzi G. Angiotensin-converting enzyme inhibition and calcium channel blockade both normalize early hyperfilteration in experimental diabetes, but only the former prevents late renal structure damage. Exp. Nephrol. 2 (1994) 220-228
7. Remuzzi A., Fassi A., Sangalli F., Malanchini B., Mohamed E.I., Bertani T., and Remuzzi G. Prevention of renal injury in diabetic MWF rats by angiotensin II antagonism. Exp. Nephrol. 6 (1998) 28-38
8. Singh R., Singh A.K., and Leehey D.J. A novel mechanism for angiotensin II formation in streptozotocin-diabetic rat glomeruli. Am. J. Physiol. Renal. Physiol. 288 (2005) F1183-F1190
9. Singh R., Singh A.K., Alavi N., and Leehey D.J. Mechanism of increased angiotensin II formation in glomerular mesangial cells cultured in high glucose. J. Am. Soc. Nephrol. 14 (2003) 873-880
10. Becker B.N., Yasuda T., Kondo S., Vaikunth S., Homma T., and Harris R.C. Mechanical stretch/relaxation stimulates a cellular renin-angiotensinogen system in cultured rat mesangial cells. Exp. Nephrol. 6 (1998) 57-66
11. Andrade M.C.C., Quinto B.M., Carmona A.K., Robas O.S., Boim M.A., Schor N., and Casarini D.E. Purification and characterization of angiotensin I-converting enzymes from mesangial cells in culture. J. Hypertens. 16 (1998) 2063-2074
12. Seikaly M.G., Arant Jr. B.S., and Seney Jr. F.D. Endogenous angiotensin concentrations in specific intrarenal fluid compartments in the rat. J. Clin. Invest. 86 (1990) 1352-1357
13. Re R. The nature of intracrine peptide hormone action. Hypertension 34 (1999) 534-538
14. Eggena P., Zhu J.H., Clegg K., and Barrett J.D. Nuclear angiotensin receptors induce transcription of renin and angiotensinogen mRNA. Hypertension 22 (1993) 496-501
15. Licea H., Walters M.R., and Navar L.G. Renal nuclear angiotensin II receptors in normal and hypertensive rats. Acta Physiol. Hung. 89 4 (2002) 427-438
16. Pendergrass K.D., Averill D.B., Ferrario C.M., Diz D.I., and Chappell M.C. Differential expression of nuclear AT1 receptors and angiotensin II within kidney of the male congenic mRen2. Lewis rat. Am. J. Physiol. Renal. Physiol. 290 (2006) F1497-F1506
17. 2+ mobilization by stimulating intracellular AT1 receptors in proximal tubules. Am. J. Physiol. Renal Physiol. 290 (2006) F1382-F1390
18. Baker K.M., and Kumar R. Intracellular angiotensin II induces cell proliferation independent of AT1 receptor. Am. J. Physiol. Cell Physiol. 291 5 (2006) C995-C1001
19. Wei C.C., Tian B., Perry G., Meng Q.C., Chen Y.F., Oparil S., and Dell'Italia L.J. Differential Ang II generation in plasma and tissue of mice with decreased expression of the ACE gene. Am. J. Physiol. Heart Cir. Physiol. 282 (2002) H2254-H2258
20. Huang X.R., Chen W.Y., Truong L.D., and Lan H.Y. Chymase is upregulated in diabetic nephropathy: implications for an alternative pathway of angiotensin II-mediated diabetic renal and vascular disease. J. Am. Soc. Nephrol. 14 (2003) 1952-1954